GeoVax Labs
GOVX
10 hedge funds and large institutions have $619K invested in GeoVax Labs in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
29% more capital invested
Capital invested by funds: $481K → $619K (+$138K)
25% more funds holding
Funds holding: 8 → 10 (+2)
0.14% less ownership
Funds ownership: 0.44% → 0.31% (-0.14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$78.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.88K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.79K |
| 4 |
Morgan Stanley
New York
|
+$2.24K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$176 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$172K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$176 |
| 3 |
JP Morgan Chase
New York
|
-$2 |
GOVX Hedge Fund Activity: Q2 2024 in Review
10 of the 6,929 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs (GOVX) for Q2 2024, worth a combined $619K — up 29% from $481K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GOVX positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $78.7K. The largest seller was Armistice Capital, cutting an estimated $172K.
- 10 institutional investors held GeoVax Labs (GOVX) as of Q2 2024, up from 8 in Q1 2024.
- Funds reported $619K of GeoVax Labs stock for Q2 2024, up 29% quarter-over-quarter.
- 2 funds opened new GeoVax Labs positions in Q2 2024 and 0 closed out, a net change of +2 holders.
- The largest GeoVax Labs buyer in Q2 2024 was Bank of America, an estimated $78.7K added.
- The largest GeoVax Labs seller in Q2 2024 was Armistice Capital, an estimated $172K sold.
Based on aggregated 13F filings for Q2 2024.